New antibiotics needed

In 2010, the Infectious Diseases Society of America (IDSA) issued a statement warning: “The time has come for a global commitment to develop new antibacterial drugs. Current data document the impending disaster due to the confluence of decreasing investment in antibacterial drug research and development concomitant with the documented rapid increase in the level of resistance to currently licensed drugs.”

The article further stated: “Advanced interventions currently taken for granted — for